lovastatin   Click here for help

GtoPdb Ligand ID: 2739

Synonyms: (+)-mevinolin | 6α-methylcompactin | Mevacor®
Approved drug PDB Ligand Immunopharmacology Ligand
lovastatin is an approved drug (FDA (1987))
Compound class: Natural product or derivative
Comment: Lovastatin is a 3-hydroxy-3-methylglutaryl-CoA reductase (HMG-CoA) inhibitor; a statin drug used for the prevention of cardiovascular diseases.
NB: there may be ambiguity in the chiral specification in the reported literature, compared to the structure represented here.
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: lovastatin

lovastatin is commercially available from our sponsors

2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 72.83
Molecular weight 404.26
XLogP 4.57
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES CCC(C(=O)OC1CC(C)C=C2C1C(CCC1CC(O)CC(=O)O1)C(C=C2)C)C
Isomeric SMILES CC[C@@H](C(=O)O[C@H]1C[C@@H](C)C=C2[C@H]1[C@@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@H](C=C2)C)C
InChI InChI=1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3/t14-,15-,16-,18+,19+,20-,21-,23-/m0/s1
InChI Key PCZOHLXUXFIOCF-BXMDZJJMSA-N
Selectivity at nuclear hormone receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Pregnane X receptor Hs Agonist Full agonist 5.3 – 6.0 pEC50 - 7
⤷ pEC50 5.3 – 6.0 (EC50 5x10-6 – 1x10-6 M) [7]
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
hydroxymethylglutaryl-CoA reductase Primary target of this compound Hs Inhibitor Competitive 9.2 pKi - 1
⤷ pKi 9.2 (Ki 6x10-10 M) [1]
Description: Inhibition of HMG-CoA reductase
Conditions: Substrate concentrations: 200µM NADPH, HMG-CoA concentration varied- 17.5µM, 34.8µM or 52.1µM
hydroxymethylglutaryl-CoA reductase Mm Inhibitor Competitive 7.6 pIC50 - 2
⤷ pIC50 7.6 (IC50 2.7x10-8 M) [2]
Description: In vitro inhibition of HMG-CoA reductase
Conditions: Isolated enzyme HMG-CoA reductase
hydroxymethylglutaryl-CoA reductase Primary target of this compound Hs Inhibitor Competitive 7.3 – 7.7 pIC50 - 5,9
⤷ pIC50 7.7 (IC50 2x10-8 M) [9]
Description: in vitro inhition of HMG-CoA reductase
Conditions: Inhibitory activity assay used partially purified microsomal preparations.
pIC50 7.3 (IC50 5x10-8 M) [5]
Description: in vitro inhibition of HMG-CoA reductase
Conditions: Substrate concentrations: NADP 50mM, 0.91 mM HMG-CoA. Inhibition of cellular HMG-CoA reductase in cultures of hepatic cells (HEP G2, a human hepatoma cell line)
hydroxymethylglutaryl-CoA reductase Rn Inhibitor Competitive 6.3 – 8.5 pIC50 - 2,4-6,8,10
⤷ pIC50 8.5 (IC50 3x10-9 M) [8]
Description: in vitro inhition of HMG-CoA reductase
Conditions: Inhibition of rat liver microsomal HMG-CoA reductase. Sodium salt preparation used.
pIC50 8.1 (IC50 8x10-9 M) [6]
Description: in vitro inhibition of HMG-CoA reductase
Conditions: Substrate concentrations: 0.91mM HMG-CoA, 50mM NADP. Inhibition of HMG-CoA reductase in solubilized rat liver.
pIC50 8.1 (IC50 8x10-9 M) [5]
Description: in vitro inhibition of HMG-CoA reductase
Conditions: In vitro inhibition of HMG-CoA reductase in solubilized rat liver.
pIC50 8.0 (IC50 1.1x10-8 M) [2]
Description: in vitro inhibition of HMG-CoA reductase
Conditions: Inhibition of microsomal rat liver HMG-CoA reductase
pIC50 7.6 (IC50 2.7x10-8 M) [10]
Description: in vitro inhition of HMG-CoA reductase
Conditions: Substrate concentrations: 0.45 µM HMG-CoA, 4mM NADPH. Compound was evaluated for the inhibition of HMG-CoA reductase (COR) in rats.
pIC50 6.8 (IC50 1.6x10-7 M) [4]
Description: in vitro inhition of HMG-CoA reductase
Conditions: The Na+ salt of mevinoline was tested for HMG-CoA reductase inhibitory activity in a microsomal preparation
pIC50 6.3 (IC50 5.3x10-7 M) [4]
Description: in vitro inhition of HMG-CoA reductase
Conditions: The lactone form of lovastatin was tested for HMG-CoA reductase inhibitory activity in a microsomal preparation